Skip to main content

Advertisement

ADVERTISEMENT

Q&As

Q&A: Erik Stratman, MD, on Managing Cutaneous Manifestations of Rheumatologic Diseases
Q&As
02/26/2020
Erik Stratman, MD, presented on cutaneous manifestations of rheumatologic diseases at the ODAC Dermatology, Aesthetics, and Surgery Conference. He shared pearls with The Dermatologist on diagnosing and treating these conditions.
Erik Stratman, MD, presented on cutaneous manifestations of rheumatologic diseases at the ODAC Dermatology, Aesthetics, and Surgery Conference. He shared pearls with The Dermatologist on diagnosing and treating these conditions.
Erik Stratman, MD, presented on...
02/26/2020
Autoimmune

Advertisement

Q&As
11/12/2019
This Saturday, the American Autoimmune Related Diseases Association (AARDA) and Allegheny Health Network Autoimmunity Institute will hold a free public forum for patients and providers on what everyone needs to know about autoimmune disease....
This Saturday, the American Autoimmune Related Diseases Association (AARDA) and Allegheny Health Network Autoimmunity Institute will hold a free public forum for patients and providers on what everyone needs to know about autoimmune disease....
This Saturday, the American...
11/12/2019
Autoimmune
Dr Joseph Merola
Q&As
08/08/2019
Lourdes M. Perez-Chada, MD, MMSc, Sara Jiayang Li, BS, and Joseph F. Merola, MD, MMSc, discuss a novel treatment algorithm for managing patients treated with anti-TNF inhibitors who develop this adverse event.
Lourdes M. Perez-Chada, MD, MMSc, Sara Jiayang Li, BS, and Joseph F. Merola, MD, MMSc, discuss a novel treatment algorithm for managing patients treated with anti-TNF inhibitors who develop this adverse event.
Lourdes M. Perez-Chada, MD,...
08/08/2019
The Dermatologist
Q&As
07/03/2019
The impact of smoking on disease severity in axial spondyloarthritis (SpA) has not been thoroughly explained. In a cross-sectional study, Sizheng Steven Zhao, MBChB(Hons), MRCP, from the Institute of Ageing and Chronic...
The impact of smoking on disease severity in axial spondyloarthritis (SpA) has not been thoroughly explained. In a cross-sectional study, Sizheng Steven Zhao, MBChB(Hons), MRCP, from the Institute of Ageing and Chronic...
The impact of smoking on...
07/03/2019
Autoimmune

Advertisement

Q&As
06/14/2019
Alexis Ogdie-Beatty, MD, MSCE, from the University of Pennsylvania, answers our questions about her study on the diagnostic process among men and women with AS.
Alexis Ogdie-Beatty, MD, MSCE, from the University of Pennsylvania, answers our questions about her study on the diagnostic process among men and women with AS.
Alexis Ogdie-Beatty, MD, MSCE,...
06/14/2019
Autoimmune
Q&As
05/03/2019
Chronic inflammation of the spine and the sacroiliac joints are common in ankylosing spondylitis (AS). Previous studies have assessed whether diet can impact manifestations of AS and reduce inflammation. However, whether a specific...
Chronic inflammation of the spine and the sacroiliac joints are common in ankylosing spondylitis (AS). Previous studies have assessed whether diet can impact manifestations of AS and reduce inflammation. However, whether a specific...
Chronic inflammation of...
05/03/2019
Autoimmune
Q&As
01/22/2017
A recent study examined the association between depression and the risk of developing psoriatic arthritis in patients with psoriasis.
A recent study examined the association between depression and the risk of developing psoriatic arthritis in patients with psoriasis.
A recent study examined the...
01/22/2017
Autoimmune

Advertisement

Q&As
01/19/2016
Findings from a phase 2b clinical trial showed delgocitinib was effective for atopic dermatitis. Margitta Worm, MD, discussed these findings and their implications in an interview with ALN.
Findings from a phase 2b clinical trial showed delgocitinib was effective for atopic dermatitis. Margitta Worm, MD, discussed these findings and their implications in an interview with ALN.
Findings from a phase 2b...
01/19/2016
Autoimmune

Advertisement